Provide notes on each slide, indicating what you would say if you were actually presenting in front of an audience.

To my writer,
I need you to write an eight (8) slide presentation in which you:
1. Provide a title slide followed by a slide with an introduction to your presentation.
2. The presentation should include your choice of five (5) challenges that you believe organizations will face in the next 20 years. Only include one (1) challenge and your explanation for choosing that challenge per slide for a total of five (5) slides.
3. Provide one (1) summary slide which addresses key points of your paper.
4. Provide notes on each slide, indicating what you would say if you were actually presenting in front of an audience.

Perform a vertical analysis in relation to revenue for the items on the income statement only for each of the two companies.

Section 1: Vertical Analysis (Common Size Analysis)
Perform a vertical analysis in relation to revenue for the items on the income statement only for each of the two companies. (18 marks)

Section 2: Ratio Analysis
Compute the ratios for the following categories for each company:
Profitability
Liquidity
Solvency
market value
Present in chart form and show calculations used. (36 marks)

Discussion of ratios (46 marks) For each ratio, students should comment on some of the following
What is the relative position of each of the corporations?
What is being measured?
What does it mean? Is this good news or bad

Section 3: Conclusions/Recommendations
Draw conclusions from the data that was gathered in the previous sections and determine the relevant position of each of the corporations in all of the analyses.
The conclusions/recommendations must address the following as a comparison between the two companies.
Summarize the overall strengths and weaknesses of each corporation?
Your final recommendation as to which company your client should invest in explaining key reasons why it is the better choice.

Bailey Ltd.
Balance Sheet
As at December 31, 2016

Cash $66,000
Accounts Receivable(net) *** 241,000
Inventory 87,000
Prepaid Expenses 12,000
Plant and Equipment(net) 792,000
$1,198,000
Accounts Payable & Accrued Liabilities $191,000
Long-term Debt 635,000
Common Shares** 50,000
Retained Earnings 322,000
$1,198,000
Bailey Ltd.
Income Statement
For the year ended December 31, 2016
Sales * $2,797,000
Cost of Goods Sold 1,790,000
Gross Margin 1,007,000
Operating Expenses 770,000
Depreciation Expense 37,000
Operating Income 200,000
Interest Expense 70,000
Income before Income Tax 130,000
Income Tax Expense 52,000
Net Income(Loss) $78,000
** Avg. common shares issued and outstanding 22,000 shares
*** A/R for 2015 was $230,000
Equity for 2015 was $310,000
total assets for 2015 was $1,050,000
inventory for 2015 85,000
dividend 2016 60,000

Snoopy Ltd.
Balance Sheet
As at December 31, 2016

Cash $27,000
Accounts Receivable(net)*** 262,000
Inventory 110,000
Prepaid Expenses 7,000
Plant and Equipment(net) 704,000
$1,110,000
Accounts Payable & Accrued Liabilities $173,000
Long-term Debt 310,000
Common Shares** 200,000
Retained Earnings 427,000
$1,110,000
** Avg. common shares issued and outstanding 25,000 shares
*** A/R for 2015 was 230,000
Equity for 2015 was $620,000
Total assets for 2015 was 1,000,000
inventory for 2015 112,000
dividend 2016 55,0

Bailey Ltd.
Balance Sheet
As at December 31, 2016

Cash $66,000
Accounts Receivable(net) *** 241,000
Inventory 87,000
Prepaid Expenses 12,000
Plant and Equipment(net) 792,000
$1,198,000
Accounts Payable & Accrued Liabilities $191,000
Long-term Debt 635,000
Common Shares** 50,000
Retained Earnings 322,000
$1,198,000
Bailey Ltd.
Income Statement
For the year ended December 31, 2016
Sales * $2,797,000
Cost of Goods Sold 1,790,000
Gross Margin 1,007,000
Operating Expenses 770,000
Depreciation Expense 37,000
Operating Income 200,000
Interest Expense 70,000
Income before Income Tax 130,000
Income Tax Expense 52,000
Net Income(Loss) $78,000
** Avg. common shares issued and outstanding 22,000 shares
*** A/R for 2015 was $230,000
Equity for 2015 was $310,000
total assets for 2015 was $1,050,000
inventory for 2015 85,000
dividend 2016 60,000

Snoopy Ltd.
Balance Sheet
As at December 31, 2016

Cash $27,000
Accounts Receivable(net)*** 262,000
Inventory 110,000
Prepaid Expenses 7,000
Plant and Equipment(net) 704,000
$1,110,000
Accounts Payable & Accrued Liabilities $173,000
Long-term Debt 310,000
Common Shares** 200,000
Retained Earnings 427,000
$1,110,000
** Avg. common shares issued and outstanding 25,000 shares
*** A/R for 2015 was 230,000
Equity for 2015 was $620,000
Total assets for 2015 was 1,000,000
inventory for 2015 112,000
dividend 2016 55,000

* all Sales made on credit

Snoopy Ltd.
Balance Sheet
As at December 31, 2016

Cash $27,000
Accounts Receivable(net)*** 262,000
Inventory 110,000
Prepaid Expenses 7,000
Plant and Equipment(net) 704,000
$1,110,000
Accounts Payable & Accrued Liabilities $173,000
Long-term Debt 310,000
Common Shares** 200,000
Retained Earnings 427,000
$1,110,000
** Avg. common shares issued and outstanding 25,000 shares
*** A/R for 2015 was 230,000
Equity for 2015 was $620,000
Total assets for 2015 was 1,000,000
inventory for 2015 112,000
dividend 2016 55,000

* all Sales made on credit

Snoopy Ltd.
Income Statement
For the year ended December 31, 2016
Sales * $2,454,000
Cost of Goods Sold 1,594,000
Gross Margin 860,000
Operating Expenses 632,000
Depreciation Expense 31,000
Operating Income 197,000
Interest Expense 43,000
Income before Income Tax 154,000
Income Tax Expense 62,000
Net Income(Loss) 92,000

* all Sales made on credit

Ratios to use

Profitability
Gross profit margin Gross profit Sales Revenue (Net sales)
EBIT Earnings before Interest & Tax Net Income + Interest + Inc. Taxes
EBIT to percentage of sales EBIT Sales Revenue (Net sales)
Net profit margin Net income Sales Revenue (Net sales)
Return on equity Net income avg Total shareholders equity
Return on assets Net income avg. Total assets
Asset turnover Sales Revenue (Net sales) avg. total assets

Liquidity (short-term)
Current ratio Current assets current liabilities
quick ratio (cash + s/t investments + A/R) current liabilities
DSO (avg. A/R net credit sales ) 365
ART Net credit sales avg. A/R
Inventory days on hand (avg. inventory CoGs ) 365
inventory turnover CoGs avg. inventory

Solvency (long-term)
Interest coverage EBIT interest expense
debt to equity ratio Total liabilities Total shareholders equity
Debt to assets Total liabilities Total Assets

Market value
Book value per share (shareholders equity preferred equity) # common shares outstanding
dividend payout Dividends paid in a year net income
EPS (net income preferred dividend) wtd avg # common shares

Financial Statement Analysis

You are a financial analyst and your client has approached you for some independent financial assistance. He is considering investing funds in common shares of a corporation and has identified two alternatives. They are both in the same industry and either could be bought for book value. Your client is requesting your advice on which would be the better investment.

As a financial analyst you will prepare a prospectus. A prospectus is a short description of the analysis and must include the following sections:
1. Title page
2. Vertical Analysis
3. Ratio Analysis
4. Conclusions/Recommendations

Your prospectus should be no more than 5 pages typed not including the title page.

Ratios to use

Profitability
Gross profit margin Gross profit Sales Revenue (Net sales)
EBIT Earnings before Interest & Tax Net Income + Interest + Inc. Taxes
EBIT to percentage of sales EBIT Sales Revenue (Net sales)
Net profit margin Net income Sales Revenue (Net sales)
Return on equity Net income avg Total shareholders equity
Return on assets Net income avg. Total assets
Asset turnover Sales Revenue (Net sales) avg. total assets

Liquidity (short-term)
Current ratio Current assets current liabilities
quick ratio (cash + s/t investments + A/R) current liabilities
DSO (avg. A/R net credit sales ) 365
ART Net credit sales avg. A/R
Inventory days on hand (avg. inventory CoGs ) 365
inventory turnover CoGs avg. inventory

Solvency (long-term)
Interest coverage EBIT interest expense
debt to equity ratio Total liabilities Total shareholders equity
Debt to assets Total liabilities Total Assets

Market value
Book value per share (shareholders equity preferred equity) # common shares outstanding
dividend payout Dividends paid in a year net income
EPS (net income preferred dividend) wtd avg # common shares

Financial Statement Analysis

You are a financial analyst and your client has approached you for some independent financial assistance. He is considering investing funds in common shares of a corporation and has identified two alternatives. They are both in the same industry and either could be bought for book value. Your client is requesting your advice on which would be the better investment.

Evaluate a company’s recent actions (within the last six months) dealing with risk and uncertainty.

Select a company of your choice, one that has been dealing with risk and uncertainty within the last six months, and write a 68 page paper in which you:

Evaluate a company’s recent actions (within the last six months) dealing with risk and uncertainty.
Offer advice for improving risk management.
Examine an adverse selection problem your company is facing and recommend how it should minimize its negative impact on transactions.
Determine the ways your company is dealing with the moral hazard problem and suggest best practices used in the industry to deal with it.
Identify a principal-agent problem in your company and evaluate the tools it uses to align incentives and improve profitability.
Examine the organizational structure of your company and suggest ways it can be changed to improve the overall profitability.
Use at least five quality academic resources in this assignment. One reference must be about the risk and uncertainty the company has faced in the last six months.
Note: Wikipedia, Investopedia, Course Hero, and similar websites are not acceptable references.
For the best results in your search for resource material, visit the Research Hub.

Promoting Safety, Independence, and Least Restrictive Environment.

Promoting Safety, Independence, and Least Restrictive Environments

Purpose of Assignment:

The purpose of this assignment is to demonstrate an understanding of safe post-operative care for older adults, including discharge options that promote an independent and least restrictive options.

Instructions:

Content:

Your 70-year-old client, Max, is 1 hour post-op following a total hip replacement. On arrival to his room, Max tells you that his hip pain is an 8 on a scale of 1-10. As per the doctors order, you administer Demerol 50 mg IM. Max is usually up ad lib, and alert and oriented. However, he is a little sleepy and confused following the pain medication.

In a Word document, answer the following:

What safety concerns exist for Max?
What interventions would we take to insure Maxs safety?
Is Demerol a good choice for 70-year-old Max? Why or why not?
You are in a discharge meeting for Max which is also attended by Maxs wife, the RN leading the team today, physical therapy, and a pharmacist. Maxs wife would like him to return home, but isnt sure how she will manage. What type of services could help Max safely return home?

Create a handout, pamphlet, or other resource that you might give to a patient that would help explain the concepts of pharmacokinetics and pharmacodynamics as they relate to psychiatric medications.

Directions

Create a handout, pamphlet, or other resource that you might give to a patient that would help explain the concepts of pharmacokinetics and pharmacodynamics as they relate to psychiatric medications.

Be sure your resource addresses the following concepts:

Absorption
Bioavailability
Clearance
Distribution
Elimination
Half-life
Metabolism
Plasma concentration
Steady-state

Include a reference list for any sources cited.

Describe Pharmacokinetics and Pharmacodynamics.

Directions

Create a handout, pamphlet, or other resource that you might give to a patient that would help explain the concepts of pharmacokinetics and pharmacodynamics as they relate to psychiatric medications.

Be sure your resource addresses the following concepts:

Absorption
Bioavailability
Clearance
Distribution
Elimination
Half-life
Metabolism
Plasma concentration
Steady-state